Partners HealthCare System Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Partners HealthCare System Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C3308
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:53
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Partners HealthCare System Inc (PHS) is a non-profit integrated healthcare organization. It operates a network of community and specialty hospitals, a physician network, managed care organizations, home health and long-term care centers, community health centers and other healthcare entities. The organization focuses on providing patient care, research, teaching, and other services to patients and their families in the community through its network. It offers a wide range of services primarily to patients from the Greater Boston area along with New England and beyond. PHS holds expertise in the area of biomedical research, and is a principal teaching affiliate of Harvard Medical School. Brigham Women’s Hospital and Massachusetts General Hospital established the organization. PHS is headquartered at Boston, Massachusetts, the US.

Partners HealthCare System Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Partners HealthCare System Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Partners HealthCare System Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Partners HealthCare System Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Partners HealthCare System Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Partners HealthCare System Inc, Medical Devices Deals, 2012 to YTD 2018 10
Partners HealthCare System Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Partners HealthCare System Inc, Pharmaceuticals & Healthcare, Deal Details 15
Asset Purchase 15
Partners HealthCare Receives Approval from State Attorney General to Acquire South Shore Hospital 15
Partners HealthCare To Acquire Two Hospitals From Hallmark Health 16
Venture Financing 17
Akouos Raises USD50 Million in Series A Financing 17
SwanBio Therapeutics Raises USD25 Million in First Tranche of Series A Venture financing 18
Akouos Raises USD7.5 Million in Seed Financing 19
Magenta Therapeutics Raises USD50 Million in Series B Financing 20
Syntimmune Raises USD8 Million in Final Tranche of Series A Financing Round 22
ImmuneXcite Raises USD8.6 Million in Series A-1 Financing 23
Syntimmune Raises USD10 Million in Second Tranche of Series A Financing Round 24
Spero Therapeutics Raises USD30 Million in Series B Funding 25
Editas Medicine Raises USD120 Million in Series B Financing 26
Spero Therapeutics Raises USD30 Million in Extended Series A Financing 28
Lysosomal Therapeutics Raises USD20 Million in Series A Financing 30
Quartet Medicine Raises USD17 Million in Series A Venture Financing 31
Raze Therapeutics Raises USD24 Million in Series A Venture Financing 32
Lysosomal Therapeutics Raises US$4.8 Million In Seed Financing 34
Spero Therapeutics Raises USD3 Million in Series A Venture Financing 36
Editas Medicine Raises US$43 Million In Series A Financing 37
Annovation BioPharma Raises US$8 Million In Series A Financing 38
RaNA Therapeutics Raises Additional US$18 Million In Series A Financing 39
Partnerships 41
Jiahui International Hospital, Partners HealthCare International and Brigham and Women’s Hospital to Co-Develop Women’s Health Center 41
Partners HealthCare to Form Joint Venture with MedSpring Urgent Care 42
Acquisition 43
Novartis Acquires CoStim Pharma 43
Partners HealthCare Completes Acquisition Of Cooley Dickinson Hospital 45
Partners HealthCare System Inc – Key Competitors 46
Partners HealthCare System Inc – Key Employees 47
Partners HealthCare System Inc – Locations And Subsidiaries 48
Head Office 48
Other Locations & Subsidiaries 48
Joint Venture 49
Recent Developments 50
Corporate Communications 50
Aug 08, 2018: Brigham and Women’s Faulkner Hospital names David McCready as new President 50
Apr 30, 2018: Partners HealthCare Names Rosemary Rodrigues Sheehan Chief Human Resources Officer 51
Jan 25, 2017: Partners HealthCare appoints new president of NSMC 52
Appendix 53
Methodology 53
About GlobalData 53
Contact Us 53
Disclaimer 53

List of Tables
Partners HealthCare System Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Partners HealthCare System Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Partners HealthCare System Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Partners HealthCare System Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Partners HealthCare System Inc, Deals By Therapy Area, 2012 to YTD 2018 9
Partners HealthCare System Inc, Medical Devices Deals, 2012 to YTD 2018 10
Partners HealthCare System Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Partners HealthCare Receives Approval from State Attorney General to Acquire South Shore Hospital 15
Partners HealthCare To Acquire Two Hospitals From Hallmark Health 16
Akouos Raises USD50 Million in Series A Financing 17
SwanBio Therapeutics Raises USD25 Million in First Tranche of Series A Venture financing 18
Akouos Raises USD7.5 Million in Seed Financing 19
Magenta Therapeutics Raises USD50 Million in Series B Financing 20
Syntimmune Raises USD8 Million in Final Tranche of Series A Financing Round 22
ImmuneXcite Raises USD8.6 Million in Series A-1 Financing 23
Syntimmune Raises USD10 Million in Second Tranche of Series A Financing Round 24
Spero Therapeutics Raises USD30 Million in Series B Funding 25
Editas Medicine Raises USD120 Million in Series B Financing 26
Spero Therapeutics Raises USD30 Million in Extended Series A Financing 28
Lysosomal Therapeutics Raises USD20 Million in Series A Financing 30
Quartet Medicine Raises USD17 Million in Series A Venture Financing 31
Raze Therapeutics Raises USD24 Million in Series A Venture Financing 32
Lysosomal Therapeutics Raises US$4.8 Million In Seed Financing 34
Spero Therapeutics Raises USD3 Million in Series A Venture Financing 36
Editas Medicine Raises US$43 Million In Series A Financing 37
Annovation BioPharma Raises US$8 Million In Series A Financing 38
RaNA Therapeutics Raises Additional US$18 Million In Series A Financing 39
Jiahui International Hospital, Partners HealthCare International and Brigham and Women's Hospital to Co-Develop Women's Health Center 41
Partners HealthCare to Form Joint Venture with MedSpring Urgent Care 42
Novartis Acquires CoStim Pharma 43
Partners HealthCare Completes Acquisition Of Cooley Dickinson Hospital 45
Partners HealthCare System Inc, Key Competitors 46
Partners HealthCare System Inc, Key Employees 47
Partners HealthCare System Inc, Subsidiaries 48
Partners HealthCare System Inc, Joint Venture 49

List of Figures
Partners HealthCare System Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Partners HealthCare System Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Partners HealthCare System Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Partners HealthCare System Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Partners HealthCare System Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Partners HealthCare System Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Partners HealthCare System Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Partners HealthCare System Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Partners HealthCare System Inc, Medical Devices Deals, 2012 to YTD 2018 10

★海外企業調査レポート[Partners HealthCare System Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Jiangsu Hengrui Medicine Co Ltd (600276):企業の財務・戦略的SWOT分析
    Jiangsu Hengrui Medicine Co Ltd (600276) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Prism Medical Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Prism Medical Ltd (Prism Medical), a subsidiary of Handicare AB is a medical device company that manufacturer and provides durable medical equipment. The company offers products such as fixed ceiling lifts, portable ceiling lifts, portable track systems, mobile floor lifts, sling systems, ho …
  • KSK Group Berhad:企業の戦略・SWOT・財務情報
    KSK Group Berhad - Strategy, SWOT and Corporate Finance Report Summary KSK Group Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • The Greenbrier Companies, Inc.:企業の戦略・SWOT・財務分析
    The Greenbrier Companies, Inc. - Strategy, SWOT and Corporate Finance Report Summary The Greenbrier Companies, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Meredith Corporation (MDP):企業の財務・戦略的SWOT分析
    Meredith Corporation (MDP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Ashley Furniture Industries Inc:企業の戦略・SWOT・財務情報
    Ashley Furniture Industries Inc - Strategy, SWOT and Corporate Finance Report Summary Ashley Furniture Industries Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Giordano International Limited (709):企業の財務・戦略的SWOT分析
    Giordano International Limited (709) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Taiga Building Products Ltd (TBL):企業の財務・戦略的SWOT分析
    Taiga Building Products Ltd (TBL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Selective Insurance Group, Inc. (SIGI):企業の財務・戦略的SWOT分析
    Selective Insurance Group, Inc. (SIGI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • UCO Bank:企業の戦略・SWOT・財務情報
    UCO Bank - Strategy, SWOT and Corporate Finance Report Summary UCO Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Petratherm Ltd (PTR):電力:M&Aディール及び事業提携情報
    Summary Petratherm Ltd (Petratherm) is a renewable energy company that carries out the business of exploration and development of emission-free geothermal energy projects. The company holds interest in Paralana Geothermal Energy Project located 600 km north of the city of Adelaide in South Australia …
  • AECI Ltd (AFE):企業の財務・戦略的SWOT分析
    AECI Ltd (AFE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Southern California Edison Co:発電所・企業SWOT分析
    Southern California Edison Co - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key …
  • Epic Systems Corp:企業の戦略的SWOT分析
    Epic Systems Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Translate Bio Inc (TBIO):製薬・医療:M&Aディール及び事業提携情報
    Summary Translate Bio Inc (Translate Bio), formerly RaNA Therapeutics Inc is a healthcare service provider that develops therapies which targets RNA within cells in the body to selectively activate protein expression. The company provides platform oligonucleotides (oligos) are molecules designed to …
  • ValiRx Plc (VAL)-医療機器分野:企業M&A・提携分析
    Summary ValiRx Plc (ValiRx) is a biopharmaceutical company that develops technologies and therapeutic options for the treatment of cancer. The company’s products and technology include GeneICE-silencing rebellious genes, GeneICE – BCL-2, VAL201-prostate cancer, NAV3 cancer screening test and VAL401- …
  • Plenus Company Limited:企業の戦略・SWOT・財務分析
    Plenus Company Limited - Strategy, SWOT and Corporate Finance Report Summary Plenus Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Avon Products, Inc.:企業の戦略・SWOT・財務情報
    Avon Products, Inc. - Strategy, SWOT and Corporate Finance Report Summary Avon Products, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Critical Outcome Technologies Inc (COT)-製薬・医療分野:企業M&A・提携分析
    Summary Critical Outcome Technologies Inc (COTI) is a biopharmaceutical company that develops targeted therapeutics with focus on oncology. The company’s lead program COTI-2 is a novel small molecule activator of misfolded mutant p53 proteins for the treatment of ovarian and other gynecological canc …
  • Angion Biomedica Corp:製薬・医療:M&Aディール及び事業提携情報
    Summary Angion Biomedica Corp (Angion) is a clinical-stage organ restoration biopharmaceutical company that discovers and develops novel treatments for the treatment of renal and chronic organ injury and disease. The company’s pipeline products include BB3, ANG-3070, ANG-3586, ANG-4201, TBD and ANG- …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆